Assessment of Plasma Level of CTHRC-I in Patients with Rheumatoid Arthritis

Background: Rheumatoid arthritis (RA) is a chronic progressive, autoimmune disease that affects about 1.5% of the community. New markers are needed for early diagnosis of RA as seronegativity in early RA remains a major limitation of both anti-citrullinated protein antibodies (ACPA) and rhe...

Full description

Bibliographic Details
Main Authors: Sahar Alwan, Raja Abdul-Ridha, Alaa Ali
Format: Article
Language:English
Published: Al-Nahrain University/College of medicine 2021-12-01
Series:The Iraqi Journal of Medical Sciences
Online Access:https://www.iraqijms.net/index.php?do=view&type=article&id=799